Follow the people · Insider
Deborah Stein
Deborah Stein files insider transactions with the SEC as a director of Rb Global. We hold 4 disclosed purchases and sales filed since 16 May 2024, 2 of them in the last 90 days.
- Files forRBA
- Disclosed buys and sells4 in all, 2 in the last 90 days
- Last disclosure10 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 May 2024 — 9 September 2026Director · Rb Global 28 Form 4 lines · source: SEC Form 4
Every transaction
28 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 300 shares | up +2.8% | up +3.8% |
| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 200 shares | up +2.8% | up +3.8% |
| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 300 shares | up +2.8% | up +3.8% |
| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 200 shares | up +2.8% | up +3.8% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | was grantednot a trade | Rb Globalderivative | 8 shares | down −24.4% | down −22.9% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | was grantednot a trade | Rb Globalderivative | 5 shares | down −24.4% | down −22.9% |
| 18 Jun 2026 | 23 Jun 2026SEC Form 4 | 5 d | was grantednot a trade | Rb Globalderivative | 6 shares | down −24.4% | down −22.9% |
| 19 May 2026 | 19 May 2026SEC Form 4 | 0 d | bought on the open market | Rb Global | 425 shares | down −19.1% | down −19.1% |
| 15 May 2026 | 18 May 2026SEC Form 4 | 3 d | was grantednot a trade | Rb Globalderivative | 1,965 shares | down −18.1% | down −18.7% |
| 18 Mar 2026 | 19 Mar 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 400 shares | down −13.9% | down −12.8% |
| 18 Mar 2026 | 19 Mar 2026SEC Form 4 | 1 d | bought on the open market | Rb Global | 400 shares | down −13.9% | down −12.8% |
| 2 Mar 2026 | 4 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 8 shares | down −16.5% | down −19.0% |
| 2 Mar 2026 | 4 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 6 shares | down −16.5% | down −19.0% |
| 2 Mar 2026 | 4 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 8 shares | down −16.5% | down −19.0% |
| 2 Mar 2026 | 4 Mar 2026SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 6 shares | down −16.5% | down −19.0% |
| 17 Dec 2025 | 19 Dec 2025SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 8 shares | down −19.6% | down −19.7% |
| 17 Dec 2025 | 19 Dec 2025SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 6 shares | down −19.6% | down −19.7% |
| 13 Nov 2025 | 13 Nov 2025SEC Form 4 | 0 d | bought on the open market | Rb Global | 1,000 shares | down −17.0% | down −17.0% |
| 18 Sep 2025 | 22 Sep 2025SEC Form 4 | 4 d | was grantednot a trade | Rb Globalderivative | 7 shares | down −29.1% | down −27.2% |
| 18 Sep 2025 | 22 Sep 2025SEC Form 4 | 4 d | was grantednot a trade | Rb Globalderivative | 5 shares | down −29.1% | down −27.2% |
| 20 Jun 2025 | 24 Jun 2025SEC Form 4 | 4 d | was grantednot a trade | Rb Globalderivative | 8 shares | down −20.2% | down −20.8% |
| 20 Jun 2025 | 24 Jun 2025SEC Form 4 | 4 d | was grantednot a trade | Rb Globalderivative | 5 shares | down −20.2% | down −20.8% |
| 15 May 2025 | 16 May 2025SEC Form 4 | 1 d | was grantednot a trade | Rb Globalderivative | 1,896 shares | down −21.8% | down −22.7% |
| 3 Mar 2025 | 5 Mar 2025SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 7 shares | down −18.6% | down −16.6% |
| 18 Dec 2024 | 20 Dec 2024SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 9 shares | down −8.0% | down −7.6% |
| 18 Sep 2024 | 20 Sep 2024SEC Form 4 | 2 d | was grantednot a trade | Rb Globalderivative | 9 shares | down −0.4% | down −1.0% |
| 20 Jun 2024 | 24 Jun 2024SEC Form 4 | 4 d | was grantednot a trade | Rb Globalderivative | 9 shares | up +6.9% | up +6.9% |
| 15 May 2024 | 16 May 2024SEC Form 4 | 1 d | was grantednot a trade | Rb Globalderivative | 2,630 shares | up +9.9% | up +11.4% |
Both percentages are the stock’s move, not Deborah Stein’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 28 of the 28 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.